| 中文名 | N-[[4-(5-甲基-3-苯基-4-异恶唑基)苯基]磺酰基]乙酰胺 |
|---|---|
| 英文名 | N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylacetamide |
| 中文别名 |
帕瑞考昔钠杂质12
帕瑞昔布钠杂质,PR-12-E 帕瑞考昔杂质8 伐地昔布杂质10 A帕瑞昔布杂质10 帕瑞昔布杂质33 帕瑞昔布杂质10 N-((4-(5-甲基-3-苯基异噁唑-4-基)苯基)磺酰基)乙酰胺 帕瑞昔布杂质03 帕瑞昔布杂质022 帕瑞昔布杂质10伐地考昔杂质10 帕瑞昔布钠杂质B对照品 帕瑞昔布标准品008 伐地考昔杂质10 VVALDECOXIB杂质 伐地考昔杂质7 帕瑞昔布钠杂质18 4-(5-甲基-3-苯基-异噁唑基)-N-乙酰基苯磺酰胺 帕瑞考昔钠杂质L |
| 英文别名 |
N-ACETYL-4-(5-METHYL-3-PHENYL-ISOXAZOL-4-YL)-BENZENESULFONAMIDE
Pecoxib sodium Impurity 16 N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]acetamide Pecoxib Impurity 10 Pecoxib-008 Pecoxib Sodium Impurity 18 Pecoxib Sodium Impurity X Pecoxib Sodium Impurity 12 N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acet N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}acetamide Pecoxib Impurity C(Valdecoxib Impurity) PECOXIB SODIUM G Parecoxib Impurity 8 Pecoxib Sodium-16 N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide AcetaMide, N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl] Pecoxib Sodium Impurity I Valdecoxib Impurity 10 N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl) Pecoxib impurity 9/N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetamide |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 分子式 | C18H16N2O4S |
| 分子量 | 356.396 |
| 精确质量 | 356.083069 |
| PSA | 101.14000 |
| LogP | 1.19 |
| 折射率 | 1.587 |
| 储存条件 | 室温 |
| 海关编码 | 2934999090 |
|---|
|
~87%
198471-06-6 |
| 文献:Talley, John J.; Bertenshaw, Stephen R.; Brown, David L.; Carter, Jeffery S.; Graneto, Matthew J.; Kellogg, Michael S.; Koboldt, Carol M.; Yuan, Jinhua; Zhang, Yan Y.; Seibert, Karen Journal of Medicinal Chemistry, 2000 , vol. 43, # 9 p. 1661 - 1663 |
| 上游产品 2 | |
|---|---|
| 下游产品 0 | |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |